SunCoke Energy (SXC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Q2 2025 consolidated adjusted EBITDA was $43.6 million, down $19.9 million year-over-year, mainly due to lower contract coke sales, weaker spot margins, and reduced logistics volumes.
Net income for Q2 2025 was $3.5 million, or $0.02 per diluted share, down from $23.3 million and $0.25 per share year-over-year.
Announced $325 million acquisition of Phoenix Global, expected to close August 1, 2025, with all regulatory approvals received and anticipated to be immediately accretive.
Extended revolving credit facility to July 2030, with liquidity at $536.2 million at quarter-end.
Declared a $0.12 per share dividend payable September 2, 2025.
Financial highlights
Q2 2025 revenue was $434.1 million, down from $470.9 million year-over-year; net income attributable was $0.02 per share.
Adjusted EBITDA for Q2 2025 was $43.6 million, down from $63.5 million; domestic coke adjusted EBITDA was $40.5 million with sales volumes of 943,000 tons.
Logistics segment adjusted EBITDA was $7.7 million, with 4.8 million tons throughput.
Cash balance at quarter-end was $186.2 million; revolver undrawn at $350 million.
Operating cash flow for the first six months was $43.3 million, up from $0.7 million year-over-year.
Outlook and guidance
Reaffirmed full-year 2025 consolidated adjusted EBITDA guidance of $210–$225 million and free cash flow of $103–$118 million.
Domestic coke adjusted EBITDA guidance maintained at $185–$192 million; logistics segment at $45–$50 million.
CapEx guidance lowered to approximately $60 million for the year.
Full-year 2025 net income expected between $40 million and $59 million.
Will provide updated guidance including Phoenix Global after transaction close.
Latest events from SunCoke Energy
- 2026 outlook projects EBITDA and FCF growth after a challenging 2025 with one-time impacts.SXC
Q4 202517 Feb 2026 - Q3 adjusted EBITDA hit $75.3M, net income rose, and 2024 guidance was raised on regulatory gain.SXC
Q3 202413 Feb 2026 - Q2 Adjusted EBITDA hit $63.5M, with a 20% dividend hike and strong full-year outlook.SXC
Q2 20242 Feb 2026 - 2024 Adjusted EBITDA exceeded guidance; 2025 faces margin pressure but strong liquidity persists.SXC
Q4 20249 Jan 2026 - 2025 meeting to vote on directors, pay, and auditor amid strong results and robust governance.SXC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor on May 15, 2025.SXC
Proxy Filing1 Dec 2025 - Q1 2025 profit fell on weak coke sales, but guidance and liquidity remain strong.SXC
Q1 202528 Nov 2025 - $325M acquisition expands reach, diversifies earnings, and delivers immediate accretion and synergies.SXC
M&A Announcement25 Nov 2025 - Q3 2025 Adjusted EBITDA dropped to $59.1M, with FY guidance cut to $220–$225M after a contract breach.SXC
Q3 202513 Nov 2025